Intralesional Therapy

Intralesional Therapy

This CME Activity evaluates the clinical safety and efficacy profiles of n…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Intralesional PV-10 Chemoablation

Intralesional PV-10 Chemoablation

In this CME activity, Dr. Sanjiv S. Agarwala discusses the rationale for a…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Targeted Therapy

Targeted Therapy

This CME Activity evaluates the clinical safety and efficacy profiles of n…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Immunotherapy

Immunotherapy

This CME Activity assesses the clinical utility of available and emerging …

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Sequencing/Combining Targeted Therapy and Immunotherapy

Sequencing/Combining Targeted Therapy and Immunotherapy

This CME Activity evaluates strategies for combining and sequencing target…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Oncolytic Immunotherapy and Combinations

Oncolytic Immunotherapy and Combinations

Dr. Andtbacka assesses the value of oncolytic immunotherapy alone and in c…

Expiration Date: 9/23/2016

Max Credits: 0

View Activity

Plasmid IL-12 Electroporation in Melanoma

Plasmid IL-12 Electroporation in Melanoma

Dr. Algazi assesses the value of plasmid IL-12 electroporation in treating…

Expiration Date: 9/21/2017

Max Credits: 0

View Activity

Updates in Immunotherapy: Melanoma

Updates in Immunotherapy: Melanoma

Melanoma has been at the forefront of the immuno-oncology revolution. This…

Expiration Date: 9/20/2016

Max Credits: 0

View Activity

Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

The promise of immunotherapy in oncology has become a reality with the US …

Expiration Date: 8/17/2016

Max Credits: 0

View Activity

Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

Globally, lung cancer is the leading cause of cancer-related deaths. Non-s…

Expiration Date: 8/15/2016

Max Credits: 0

View Activity